Directed new share issue in Recipharm (SE) — SEK 276 million

Carnegie acted as sole financial adviser in the directed new share issue of 2.25 million new Class B shares at a price of SEK 122.50 per share. Recipharm provides contract manufacturing and development services for other pharmaceutical companies. Manufacturing primarily involves production of pharmaceuticals in various forms.January 2016.